Stockreport

AcelRx Pharmaceutical's sufentanil sublingual tablet (DSUVIA) to be highlighted during a presentation at the Boswick Burn and Wound Symposium

AcelRx Pharmaceuticals, Inc.  (ACRX) 
Last acelrx pharmaceuticals, inc. earnings: 3/16 07:35 am Check Earnings Report
US:NASDAQ Investor Relations: ir.acelrx.com/investor-relations